Sudden cardiac death as an onset of myocardial infarction

M N Sadykov , E B Frolova , N A Tsibul'kin , E F Akhmetzyanova , I A Aynutdinova , M A Mingazetdinov , E I Aglullina , E N Yagudina

Kazan medical journal ›› 2018, Vol. 99 ›› Issue (2) : 307 -313.

PDF
Kazan medical journal ›› 2018, Vol. 99 ›› Issue (2) : 307 -313. DOI: 10.17816/KMJ2018-307
Clinical observations
research-article

Sudden cardiac death as an onset of myocardial infarction

Author information +
History +
PDF

Abstract

Sudden cardiac death is an actual problem of current cardiology. Ventricular arrhythmias are considered the main mechanism of its development: ventricular fibrillation and flutter, sustained ventricular tachycardia and asystoly. Pathological changes of electrophysiologic processes in myocardium and conducting system of ventricles are the reasons of arrhythmia development. Coronary heart disease is considered the most frequent etiological factor of sudden cardiac death. Acute ischemia in the onset of myocardial infarction can be the cause of fatal arrhythmias leading to sudden cardiac death. Well-timed cardiopulmonary resuscitation and cardioversion allow restoring the heart activity. The article presents short review of scientific medical literature on the subject of sudden cardiac death in myocardial infarction. The clinical value of this pathology is illustrated with an example from practice - a case of the onset of acute myocardial infarction in the form of sudden cardiac death.

Keywords

sudden cardiac death / ventricular fibrillation / myocardial infarction

Cite this article

Download citation ▾
M N Sadykov, E B Frolova, N A Tsibul'kin, E F Akhmetzyanova, I A Aynutdinova, M A Mingazetdinov, E I Aglullina, E N Yagudina. Sudden cardiac death as an onset of myocardial infarction. Kazan medical journal, 2018, 99(2): 307-313 DOI:10.17816/KMJ2018-307

登录浏览全文

4963

注册一个新账户 忘记密码

References

[1]

Myerburg R., Castellanos A. Braunwald’s heart disease. A textbook of cardiovascular medicine. 8th ed. P. Libby, R. Bonow, D. Mann, D. Zipes editors. Philadelphia: Saunders. 2007; 933–974.

[2]

Myerburg R., Castellanos A. Braunwald’s heart disease. A textbook of cardiovascular medicine. 8th ed. P. Libby, R. Bonow, D. Mann, D. Zipes editors. Philadelphia: Saunders. 2007; 933-974.

[3]

Murakoshi N., Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circulation J. 2013; 11 (77): 2419–2431. DOI: 10.1253/circj.CJ-13-1129.

[4]

Murakoshi N., Aonuma K. Epidemiology of arrhythmias and sudden cardiac death in Asia. Circulation J. 2013; 11 (77): 2419-2431. DOI: 10.1253/circj.CJ-13-1129.

[5]

Zaman S., Kovoor P. Sudden cardiac death early after myocardial infarction. Circulation. 2014; 129: 2426–2435. DOI: 10.1161/CIRCULATIONAHA.113.007497.

[6]

Zaman S., Kovoor P. Sudden cardiac death early after myocardial infarction. Circulation. 2014; 129: 2426-2435. DOI: 10.1161/CIRCULATIONAHA.113.007497.

[7]

Go A., Mozaffarian D., Roger V. et al. Heart disease and stroke statistics — 2014 update: a report from the American Heart Association. Circulation. 2014; 129: e28-e292. DOI: 10.1161/01.cir.0000441139.02102.80.

[8]

Go A., Mozaffarian D., Roger V. et al. Heart disease and stroke statistics - 2014 update: a report from the American Heart Association. Circulation. 2014; 129: e28-e292. DOI: 10.1161/01.cir.0000441139.02102.80.

[9]

Adabag A., Therneau T., Gersh B. et al. Sudden death after myocardial infarction. JAMA. 2008; 300: 2022–2029. DOI: 10.1001/jama.2008.553.

[10]

Adabag A., Therneau T., Gersh B. et al. Sudden death after myocardial infarction. JAMA. 2008; 300: 2022-2029. DOI: 10.1001/jama.2008.553.

[11]

Piccini J., Al-Khatib M., Hellkamp S. et al. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm. 2011; 8: 393–400. DOI: 10.1016/

[12]

Piccini J., Al-Khatib M., Hellkamp S. et al. Mortality benefits from implantable cardioverter-defibrillator therapy are not restricted to patients with remote myocardial infarction: an analysis from the Sudden Cardiac Death in Heart Failure Trial (SCD-HeFT). Heart Rhythm. 2011; 8: 393-400. DOI: 10.1016/ j.hrthm.2010.11.033.

[13]

j.hrthm.2010.11.033.

[14]

Goff D., Lloyd-Jones D., Bennett G. et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: S49-S73. DOI: 10.1161/01.cir.0000437741.48606.98.

[15]

Goff D., Lloyd-Jones D., Bennett G. et al. 2013 ACC/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014; 129: S49–S73. DOI: 10.1161/01.cir.0000437741.48606.98.

[16]

Goldberger J., Basu A., Boineau R. et al. Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014; 129: 516-526. DOI: 10.1161/CIRCULATIONAHA.113.007149.

[17]

Goldberger J., Basu A., Boineau R. et al. Risk stratification for sudden cardiac death: a plan for the future. Circulation. 2014; 129: 516–526. DOI: 10.1161/CIRCULATIONAHA.113.007149.

[18]

Sasaki S., Tomita H., Shibutani S. et al. Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circ. J. 2014; 78: 2987-2989. DOI: 10.1253/circj.CJ-14-1098.

[19]

Sasaki S., Tomita H., Shibutani S. et al. Usefulness of the wearable cardioverter-defibrillator in patients at high risk for sudden cardiac death. Circ. J. 2014; 78: 2987–2989. DOI: 10.1253/circj.CJ-14-1098.

[20]

Ottervanger J., Ramdat Misier A., Dambrink J. et al. Mortality in patients with left ventricular ejection fraction ≤30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am. J. Cardiol. 2007; 100: 793-797. DOI: 10.1016/ j.amjcard.2007.03.101.

[21]

Ottervanger J., Ramdat Misier A., Dambrink J. et al. Mortality in patients with left ventricular ejection fraction ≤30% after primary percutaneous coronary intervention for ST-elevation myocardial infarction. Am. J. Cardiol. 2007; 100: 793–797. DOI: 10.1016/

[22]

Marrugat J., Elosura R., Gil M. Epidemiology of sudden cardiac death in Spain. Rev. Esp. Cardiol. 1999; 9 (52): 717-725. DOI: 10.1016/S0300-8932(99) 74993-6.

[23]

j.amjcard.2007.03.101.

[24]

Adabag A., Luepker R., Roger V., Gersh B. Sudden cardiac death: epidemiology and risk factors. Nat. Rev. Cardiol. 2010; 7 (4): 216-225. DOI: 10.1038/nrcardio.2010.3.

[25]

Marrugat J., Elosura R., Gil M. Epidemiology of sudden cardiac death in Spain. Rev. Esp. Cardiol. 1999; 9 (52): 717–725. DOI: 10.1016/S0300-8932(99)

[26]

74993-6.

[27]

Adabag A., Luepker R., Roger V., Gersh B. Sudden cardiac death: epidemiology and risk factors. Nat. Rev. Cardiol. 2010; 7 (4): 216–225. DOI: 10.1038/nrcardio.2010.3.

RIGHTS & PERMISSIONS

Sadykov M.N., Frolova E.B., Tsibul'kin N.A., Akhmetzyanova E.F., Aynutdinova I.A., Mingazetdinov M.A., Aglullina E.I., Yagudina E.N.

AI Summary AI Mindmap
PDF

149

Accesses

0

Citation

Detail

Sections
Recommended

AI思维导图

/